Montelukast Does Not Prolong the QT Interval
Montelukast is not associated with QT interval prolongation and does not require ECG monitoring for this indication. The FDA drug label for montelukast makes no mention of QT prolongation as an adverse effect or precaution 1. Furthermore, the most recent and comprehensive 2023 Canadian Cardiovascular Society guidelines on QT interval prolongation extensively list drug classes that prolong the QT interval—including antibiotics (macrolides, fluoroquinolones), antifungals, antiarrhythmics, antipsychotics, antidepressants, antiemetics, and analgesics—but montelukast is notably absent from these lists 2.
Key Evidence
The 2023 Canadian guidelines provide a detailed mnemonic for remembering QT-prolonging drugs: the "anti's"—antibiotics, antifungals, antiarrhythmics, antipsychotics/antidepressants, antiemetics, and analgesics 2. Montelukast, a leukotriene receptor antagonist used for asthma and allergic rhinitis, does not fall into any of these categories and is not mentioned as a QT-prolonging agent.
The FDA pharmacology data for montelukast describes its mechanism as selective binding to the cysteinyl leukotriene receptor (CysLT1) without affecting other cardiac receptors such as prostanoid, cholinergic, or β-adrenergic receptors 1. The drug's metabolism occurs primarily through CYP3A4 and 2C9, with no documented effects on cardiac ion channels that would prolong ventricular repolarization 1.
Clinical Implications
- No baseline ECG required before initiating montelukast
- No routine ECG monitoring needed during montelukast therapy
- Safe to use in patients with pre-existing QT prolongation without additional cardiac risk from the medication itself
- Can be combined with other medications without concern for additive QT prolongation from montelukast
Important Distinction
While the guidelines emphasize checking resources like www.crediblemeds.org for QT-prolonging potential before prescribing medications 2, montelukast does not appear on these lists. This contrasts sharply with commonly used medications that do prolong the QT interval, such as azithromycin, fluoroquinolones, ondansetron, and certain antipsychotics 3, 4.